Quest Diagnostics (NYSE:DGX) Price Target Raised to $191.00 at Robert W. Baird
Quest Diagnostics (NYSE:DGX – Get Free Report) had its price objective lifted by equities researchers at Robert W. Baird from $190.00 to $191.00 in a note issued to investors on Thursday,Benzinga ...
New Jersey Business Magazine17h
Steve Adubato’s Lessons in Leadership: Leading Business Development
In this episode of Lessons in Leadership, Steve Adubato and Mary Gamba talk with Cecilia McKenney, SVP & Chief Human Resources Officer, Quest Diagnostics, about the keys to recruiting, training, and ...
DGX Stock Set to Benefit From New Google Cloud Partnership
Quest Diagnostics teams up with Google Cloud to streamline data and personalize customer experiences using gen AI.
GEN - Genetic Engineering and Biotechnology News22h
NVIDIA GTC 2025 Highlights Foundation Models and AI Drug Discovery
Researchers, executives, and thought leaders across healthcare gathered at NVIDIA GTC to discuss today’s pressing AI life science applications.